Intratumoral Lymphatic Vessel Density in Vulvar Squamous Cell Carcinomas: A Possible Association With Favorable Prognosis

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Citação
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, v.31, n.1, p.8-14, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Lymphatic vessels serve as major routes for regional dissemination, and therefore, lymph node status is a key indicator of prognosis. To predict lymph node metastasis, tumor lymphatic density and lymphangiogenesis-related molecules have been studied in various tumor types. To our knowledge, no previous studies have evaluated the role of intratumoral lymphatic vessel density (LVD) in the behavior of vulvar carcinomas. The aim of this study was to analyze intratumoral LVD in relation to patient survival and well-characterized prognostic factors for cancer. Thirty-five patients with vulvar squamous cell carcinoma underwent vulvectomy and dissection of regional lymph nodes. Clinical records were reviewed, in addition to histological grade, peritumoral lymphatic invasion, and depth of infiltration for each case. Tissue microarray paraffin blocks were created, and lymphatic vessels were detected using immunohistochemical staining of podoplanin (D2-40 antibody). Intratumoral LVD was quantified by counting the number of stained vessels. Higher values for intratumoral LVD were associated with low-grade and low-stage tumors, and with tumors without lymphatic invasion and reduced stromal infiltration. In a univariate analysis, high intratumoral LVD was associated with a higher rate of overall survival and a lower rate of lymph node metastasis. Our results suggest that increased intratumoral LVD is associated with favorable prognosis in vulvar squamous carcinomas.
Palavras-chave
Vulvar cancer, Lymphangiogenesis, Prognostic factors, Lymphatic vessels
Referências
  1. Al-Rawi MAA, 2011, FRONT BIOSCI-LANDMRK, V16, P723, DOI 10.2741/3715
  2. Birner P, 2001, INT J CANCER, V95, P29, DOI 10.1002/1097-0215(20010120)95:1<29::AID-IJC1005>3.0.CO;2-W
  3. Braun M, 2009, ONKOLOGIE, V32, P732, DOI 10.1159/000252795
  4. Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693
  5. Cheng X, 2009, INT J GYNECOL CANCER, V19, P158, DOI 10.1111/IGC.0b013e3181996a78
  6. Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012
  7. Gaarenstroom KN, 2003, INT J GYNECOL CANCER, V13, P522, DOI 10.1046/j.1525-1438.2003.13304.x
  8. Hall FT, 2003, ARCH OTOLARYNGOL, V129, P716, DOI 10.1001/archotol.129.7.716
  9. Hirakawa S, 2009, CANCER SCI, V100, P983, DOI 10.1111/j.1349-7006.2009.01142.x
  10. Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]
  11. Kawamura L, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-89
  12. Matsumoto K, 2007, DIS COLON RECTUM, V50, P308, DOI 10.1007/s10350-006-0792-y
  13. Maula SM, 2003, CANCER RES, V63, P1920
  14. Miyata Y, 2006, CLIN CANCER RES, V12, P800, DOI 10.1158/1078-0432.CCR-05-1284
  15. Nakamura Y, 2006, J CLIN PATHOL, V59, P77, DOI 10.1136/jcp.2005.028779
  16. Nicoletto MO, 2010, ANTICANCER RES, V30, P2311
  17. Oonk MHM, 2006, INT J GYNECOL CANCER, V16, P963, DOI 10.1111/j.1525-1438.2006.00387.x
  18. Renyi-Vamos F, 2005, CLIN CANCER RES, V11, P7344, DOI 10.1158/1078-0432.2005.CCR-05-1077
  19. Saad RS, 2010, INT J GYNECOL PATHOL, V29, P386, DOI 10.1097/PGP.0b013e3181c3cd47
  20. Sotiropoulou N, 2010, PATHOLOGY, V42, P629, DOI 10.3109/00313025.2010.522174
  21. Sundar SS, 2007, J CLIN ONCOL, V25, P4298, DOI 10.1200/JCO.2006.07.1092
  22. Suzuki H, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-287
  23. Tavassoli FA, 2003, PATHOLOGY GENETICS T
  24. van der Avoort IA, 2010, AM J OBSTET GYNECOL, V203
  25. Van der Auwera I, 2006, BRIT J CANCER, V95, P1611, DOI 10.1038/sj.bjc.6603445
  26. van der Avoort IAM, 2006, INT J GYNECOL PATHOL, V25, P22, DOI 10.1097/01.pgp.0000177646.38266.6a
  27. Wang XL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-299
  28. Zaganelli Fabricia L, 2010, Int J Gynecol Cancer, V20, P1225, DOI 10.1111/IGC.0b013e3181ead337
  29. Zhang SQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-64